P677: Implementation of pharmacogenomic DPYD-guided fluoropyrimidine dosing for cancer patients in Saskatchewan, Canada
Saved in:
| Main Authors: | Yanwei Xi, Zafar Nawaz, Fang Wu, Vijayananda Kundapur |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Genetics in Medicine Open |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2949774425010854 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DPYD Genotyping, Fluoropyrimidine Dosage and Toxicity: An Umbrella Review of Systematic Reviews
by: Sara Otero-Torres, et al.
Published: (2025-05-01) -
DPYD variant testing in candidates for fluoropyrimidine treatment: A study protocol
by: Ana Hernández-Guío, et al.
Published: (2021-05-01) -
Population-specific DPYD variants and fluoropyrimidine toxicity risk: an analysis using public genomic databases
by: Suvam Banerjee, et al.
Published: (2025-07-01) -
Implementation of DPYD testing in Bulgarian patients with cancer
by: Nelly Miteva-Marcheva, et al.
Published: (2024-12-01) -
The Migration of South African Graduates to Canada: a Survey of Medical Practitioners in Saskatchewan
by: J.D. van der Vyver, et al.
Published: (2000-02-01)